Clover Health Investments, Corp.: Form 10-Q for the period ended Mar 31, 2021
Filed with the SEC on May 17, 2021 and accepted by EDGAR at May 17, 2021, 17:19 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-01-01 to 2021-03-31 | $200.3m | us-gaap:Revenues |
| Operating income | 3 months2021-01-01 to 2021-03-31 | −$119.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-01-01 to 2021-03-31 | $1.2m | us-gaap:InterestExpense |
| Net income | 3 months2021-01-01 to 2021-03-31 | −$48.4m | us-gaap:NetIncomeLoss |
| Operating cash flow | 3 months2021-01-01 to 2021-03-31 | −$92.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2021-01-01 to 2021-03-31 | $99.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2021-03-31 | $404.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-03-31 | $809.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-03-31 | $866.9m | us-gaap:Assets |
| Current liabilities | At period end2021-03-31 | $173.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-03-31 | $278.0m | us-gaap:Liabilities |
| Long-term debt | At period end2021-03-31 | $24.3m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2021-03-31 | $585.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-21-000268. Last ingested by Listed: Nov 6, 2026, 19:00 ET. Listed shows no prices and gives no investment advice.